Zobrazeno 1 - 10
of 201
pro vyhledávání: '"Valsamo Anagnostou"'
Autor:
Paola Ghanem, Maria Fatteh, David Olayinka Kamson, Archana Balan, Michael Chang, Jessica Tao, Jaishri Blakeley, The Johns Hopkins Molecular Tumor Board Investigators, Jenna Canzoniero, Stuart A. Grossman, Kristen Marrone, Karisa C. Schreck, Valsamo Anagnostou, Christine Pratilas, Taxiarchis Botsis, Rena Xian, Chris Gocke, Tseh Ming-Lin, Eitan Halper-Stromberg, Ying Zou, Kent Hardart, Jonathan Spiker, Kory Kreimeyer, Ting He, Katie Fiallos, Dana Petry, Kala Visvanathan, Antonio Wolff, Cesar Santa-Maria, Raquel Nunez, Christian Meyer, John Laterra, Vered Stearns, Karen Smith, Deborah Armstrong, Rachel Karchin, Katerina Karaindrou, Lily Zandi, Marta Majcherska, Faith Too, Monique Makell, Jennifer Lehman, Timsy Wanchoo, Jaime Wehr, Michael Conroy, Selina Shiqing Teh.
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundDespite the putatively targetable genomic landscape of high-grade gliomas, the long-term survival benefit of genomically-tailored targeted therapies remains discouraging.MethodsUsing glioblastoma (GBM) as a representative example of high-gr
Externí odkaz:
https://doaj.org/article/5bcfd0838b504f0dae83f9e83188528c
Autor:
James Herman, Chen Hu, James White, Patrick Forde, Julie Brahmer, Victor Velculescu, Valsamo Anagnostou, Joanne Riemer, Stephen Baylin, Christine Hann, Jorge Nieva, Margaret Fitzpatrick, David Ettinger, Benjamin Levy, Christopher Cherry, Archana Balan, Noushin Niknafs, Hua-Ling Tsai, Kristen A Marrone, Blair V Landon, Michael J Topper, Ronan Kelly
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/3ada9b6e9b3e49198ad9c4764bf98548
Autor:
Julie R Brahmer, Patrick M Forde, Jarushka Naidoo, Valsamo Anagnostou, Cheng Ting Lin, Peter B Illei, Kellie N Smith, Mara Lanis, Khinh Ranh Voong, Bradley Presson, Dipika Singh, Zhen Zeng, Russell K Hales, Phuoc T Tran, Christos Georgiades, Jeffrey Thiboutout
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 10 (2023)
Stereotactic ablative body radiation (SABR) delivers high rates of local control in early-stage non-small cell lung cancer (NSCLC); however, systemic immune effects are poorly understood. Here, we evaluate the early pathologic and immunologic effects
Externí odkaz:
https://doaj.org/article/73057316b1824f259f171d6d18eefaee
Autor:
Michael J. Topper, Valsamo Anagnostou, Kristen A. Marrone, Victor E. Velculescu, Peter A. Jones, Julie R. Brahmer, Stephen B. Baylin, Galen H. Hostetter
Publikováno v:
iScience, Vol 26, Iss 7, Pp 107095- (2023)
Summary: Non-small-cell lung cancer remains a deadly form of human cancer even in the era of immunotherapy with existing immunotherapy strategies currently only benefiting a minority of patients. Therefore, the derivation of treatment options, which
Externí odkaz:
https://doaj.org/article/03f373dd0ffa4e8182f970e5fa4abeca
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 6, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/9d7bd858cff149a383171e3619d21f42
Autor:
Valsamo Anagnostou, Mark D. Stewart
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Liquid biopsies are gaining momentum as minimally invasive means for cancer detection, characterization, monitoring, and interception. Composed of five expert-opinion review articles and five accompanying expert-physician viewpoints, this Journal for
Externí odkaz:
https://doaj.org/article/ba2fa2969b394264b3d3c8ddc94aa2fa
Autor:
Susan Scott, Mark Sausen, Valsamo Anagnostou, Jennifer Jackson, Vincent Lam, Joseph C Murray, Lavanya Sivapalan, Jenna Vanliere Canzoniero, Blair Landon, Benjamin P. Levy
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Circulating cell-free tumor DNA (ctDNA) can serve as a real-time biomarker of tumor burden and provide unique insights into the evolving molecular landscape of cancers under the selective pressure of immunotherapy. Tracking the landscape of genomic a
Externí odkaz:
https://doaj.org/article/46803e6b30b54e82bb302fbe63077460
Autor:
Laura C Cappelli, Clifton O Bingham, Patrick M Forde, Evan J Lipson, Megan Schollenberger, Ami A Shah, Julie Brahmer, Valsamo Anagnostou, Erika Darrah, Jennifer Mammen
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objective Patients with inflammatory arthritis (IA) associated with immune checkpoint inhibitor (ICI) treatment for cancer are typically seronegative for anti-cyclic citrullinated peptide (CCP) antibodies and rheumatoid factor, but little is known ab
Externí odkaz:
https://doaj.org/article/aa475359aeb14e71bd548041dbec971e
Autor:
Dimitrios Mathios, Jakob Sidenius Johansen, Stephen Cristiano, Jamie E. Medina, Jillian Phallen, Klaus R. Larsen, Daniel C. Bruhm, Noushin Niknafs, Leonardo Ferreira, Vilmos Adleff, Jia Yuee Chiao, Alessandro Leal, Michael Noe, James R. White, Adith S. Arun, Carolyn Hruban, Akshaya V. Annapragada, Sarah Østrup Jensen, Mai-Britt Worm Ørntoft, Anders Husted Madsen, Beatriz Carvalho, Meike de Wit, Jacob Carey, Nicholas C. Dracopoli, Tara Maddala, Kenneth C. Fang, Anne-Renee Hartman, Patrick M. Forde, Valsamo Anagnostou, Julie R. Brahmer, Remond J. A. Fijneman, Hans Jørgen Nielsen, Gerrit A. Meijer, Claus Lindbjerg Andersen, Anders Mellemgaard, Stig E. Bojesen, Robert B. Scharpf, Victor E. Velculescu
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
DNA from tumour cells can be detected in the blood of cancer patients. Here, the authors show that cell free DNA fragmentation patterns can identify lung cancer patients and when this information is further interrogated it can be used to predict lung
Externí odkaz:
https://doaj.org/article/fce9b8c82ce14c3ea1c846a1133812f2
Autor:
Susan C. Scott, Xiaoshan M. Shao, Noushin Niknafs, Archana Balan, Gavin Pereira, Kristen A. Marrone, Vincent K. Lam, Joseph C. Murray, Josephine L. Feliciano, Benjamin P. Levy, David S. Ettinger, Christine L. Hann, Julie R. Brahmer, Patrick M. Forde, Rachel Karchin, Jarushka Naidoo, Valsamo Anagnostou
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionThe magnitude of response to immune checkpoint inhibitor (ICI) therapy may be sex-dependent, as females have lower response rates and decreased survival after ICI monotherapy. The mechanisms underlying this sex dimorphism in ICI response
Externí odkaz:
https://doaj.org/article/2f91c0b2890647729b3fe999f6a97a89